Advances in the application ofmachine learning techniques in drug discovery, design and development

Advances in Soft Computing

Volumn 36, Issue , 2006, Pages 99-110

  Barrett, S J ^a   Langdon, W B ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860389751     PISSN: 16153871     EISSN: 18600794     Source Type: Book Series    
DOI: 10.1007/978-3-540-36266-1_10     Document Type: Conference Paper

References (118)

1. Agrafiotis and Cedeno, 2002. Feature selection for structure-activity correlation using binary particle swarms. Journal of Medicinal Chemistry, 45(5): 1098-1107. (Pubitemid 34173920)
2. Amboise and McLachlan 2002. selection bias in gene extraction on the basis of microarray gene-expression data. PNAS, 99(10):6562-6566 (Pubitemid 34526172)
3. Ando and Iba, 2004. Classification of gene expression profile using combinatory method of evolutionary computation and machine learning. GP&EM, 5(2): 145-156. (Pubitemid 38497846)
4. Arimoto and Gifford, 2005. Development of CYP3A4 Inhibition Models: Comparisons of Machine-Learning Techniques and Molecular Descriptors. Journal of Biomolecular Screening, 10(3):197-205 (Pubitemid 40617157)
5. Bains et al., 2004. HERG binding specificity and binding site structure: Evidence from a fragment-based evolutionary computing SAR study. Progress in Biophysics and Molecular Biology, 86(2):205-233. (Pubitemid 39027233)
6. Banzhaf, et al., 1998. Genetic Programming An Introduction; On the Automatic Evolution of Computer Programs and its Applications; Morgan Kaufmann.
7. Bao and Sun, 2002. Identifying genes related to drug anticancer mechanisms using support vector machine. FEBS Lett. 521(1-3):109-14. (Pubitemid 34628469)
8. Barrett, SJ. (2005) INTErSECT "RoCKET" : Robust Classification and Knowledge Engineering Techniques. Presented at : 'Through Collaboration to Innovation', Centre for Advanced Instrumentation Systems, UCL, 16th February 2005.
9. Bhasin and Raghava, 2004a. GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors. Nucleic acids research, 32:W383-W389 (Pubitemid 38997364)
10. Bhasin and Raghava, 2004b. Classification of nuclear receptors based on amino acid composition and dipeptide composition. J. Biological Chemistry, 279(22):23262-23266 (Pubitemid 38685634)
11. Biesheuvel, 2005. Diagnostic Research: improvements in design and analysis. PhD thesis, Universiteit Utrecht, Holland.
12. Bock and Gough, 2003. Whole-proteome interaction mining. Bioinformatics, 19 (1), 125-135. (Pubitemid 36150189)
13. Boser et al., 1992. A training algorithm for optimal margin classifiers. 5th Annual ACM Workshop, COLT, 1992
14. Breiman, 2001. Random forests. Machine Learning, 45:5-32 (Pubitemid 32933532)
15. Breneman 2002. Caco-2 Permeability Modeling: Feature Selection via Sparse Support Vector Machines.Presented at the ADMEffox symposium at the Orlando ACS meeting, April 2002.
16. Brown et al., 2000. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl, Acad. Sci., USA 97:262-267 (Pubitemid 30055819)
17. Burbidge et al., 2001a. STAR Sparsity Through Automated Rejection. In Connectionist Models of Neurons, Learning Processes, and Artificial Intelligence: 6th International Work Conference On Artificial and Natural Neural Networks, IWANN 2001, Proceedings, Part 1, Vol. 2084; Mira, 1.; Prieto, A., Eds.; Springer: Granada, Spain, 2001.
18. Burbidge et al., 2001b. Drug design by machine learning: support vector machines for pharmaceutical data analysis. Computers in chemistry, 26(1):4-15
19. Butte, 2002. The use and analysis of microarray data. Nat. Rev. Drug Discov. 1(12):951-60 (Pubitemid 37361601)
20. Byvatov, and Schneider, 2004. SVM-Based Feature Selection for Characterization of Focused Compound Collections. J. Chern. Inf. Comput. Sci., 44(3): 993-999
21. Byvatov et al., 2005a. From Virtual to Real Screening for D3 Dopamine Receptor Ligands. ChemBioChem, 6(6):997-999 (Pubitemid 40825338)
22. Cedeno and Agrafiotis, 2003. Using particle swarms for the development of QSAR models based on K-nearest neighbor and kernel regression. J.Comput.-Aided Mol. Des.,17:255-263. (Pubitemid 37062786)
23. Chen, 2004. Support vector machine in chemistry. World Scientific, ISBN 9812389229
24. Cheng et al., 2004. Insight into the Bioactivity and Metabolism of Human Glucagon Receptor Antagonists from 3D-QSAR Analyses. QSAR & Combinatorial Science, 23(8): 603-620
25. Congdon and Septor, 2003. Phylogenetic trees using evolutionary search: Initial progress in extending gaphyl to work with genetic data. CEC, pp320-326.
26. ristianini and Shawe-Taylor, 2000. An Introduction to support vector machines and other kernel-based learning methods. Cambridge University Press ISBN: 0 521 78019 5
27. Deutsch, 2003. Evolutionary algorithms for finding optimal gene sets in micro array prediction. Bioinformatics, 19(1):45-52. (Pubitemid 36157275)
28. Dobson & Doig 2005.Predicting enzyme class from protein structure without alignments. J.Mol.Biol. ,345:187-199 (Pubitemid 39572835)
29. Doniger et al., 2002. Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms. J. of Computational Biol., 9(6): 849-864 (Pubitemid 36207918)
30. Dubey et al., 2005. Support vector machines for learning to identify the critical positions of a protein. Journal of Theoretical Biology, 234(3):351-361 (Pubitemid 40387460)
31. Fradkin, 2005. SVM in Analysis of Cross-Sectional Epidemiological Data. http://dimacs.rutgers.edu/SpecialYears/2002-EpidlEpidSeminarSlides/fradkin.pdf
32. Eberhart and Hu, 1999. Human tremor analysis using particle swarm optimization. In CEC, pp1927-1930
33. Eberhart, Kennedy and Shi, 2001, Swarm Intelligence, Morgan Kaufmann.
34. Fujarewicz and Wiench, 2003. Selecting differentially expressed genes for colon tumor classification. Int. J. Appl. Math. Comput. Sci., 13(3):327-335
35. Fung and Mangasarian, 2004. A Feature Selection Newton Method for Support Vector Machine Classification. Computational Optimization and Applications 28(2):185-202
36. Furlanello et al., 2003. Entropy-Based Gene Ranking without Selection Bias for the Predictive Classification of Microarray Data. BMC Bioinformatics, 4:54-74.
37. Guo et al., 2005. A novel statistical ligand-binding site predictor: application to ATP-binding sites. Protein Engng., Design & Selection, 18(2):65-70 (Pubitemid 40562554)
38. Guyon et al., 2002. Gene selection for cancer classification using support vector machines. Machine learning, 46(1-3):389-422 (Pubitemid 34129977)
39. Hand, 1999. Statistics and data mining: intersecting disciplines.SIGKDD Explorations, 1: 16-19
40. Hardle and Moro, 2004. Survival Analysis with Support vector Machines. Talk at Universite Rene Descartes UFR Biomedicale, Paris http://appel.rz.hu- berlin.de/Zope/ise-stat/wiwi/ise/stat/personen/wh/talks/hae-mor-SVM- %20survival040324.pdf
41. Heddad et al., 2004. Evolving regular expression-based sequence classifiers for protein nuclear localisation.In: Raidl, et al.eds.,Applications of Evolutionary Computing,LNCS 3005, 31-40
42. Hong and Cho, 2004. Lymphoma cancer classification using genetic programming with SNR features. In Keijzer, et al. eds., EuroGP, LNCS 3003, 78-88.
43. Hou and Xu, 2004. Recent development and application of virtual screening in drug discovery: an overview. Current Pharmaceutical Design, 10: 1011-1033 (Pubitemid 38380079)
44. Howard and Benson, 2003. Evolutionary computation method for pattern recognition of cisacting sites. Biosystems, 72(1-2):19-27. (Pubitemid 37464787)
45. Howley and Madden, 2005. The Genetic Kernel Support Vector Machine: Description and Evaluation". Artificial Intelligence Review, to appear.
46. Huang and Chen, 2005. Support vector machines in sonography: Application to decision making in the diagnosis of breast cancer. Clinical Imaging, 29(3):179-184 (Pubitemid 40602801)
47. Igel, 2005. Multiobjective Model Selection for Support Vector Machines. In C. A. Coello Coello, E. Zitzler, and A. Hernandez Aguirre, editors, Proc. of the Third International Conference on Evolutionary Multi-Criterion Optimization (EMO 2005), LNCS 3410: 534-546 (Pubitemid 41251788)
48. Jerebko, et al., 2005. Support vector machines committee classification method for computeraided polyp detection in CT colonography. Acad. Radiol., 12(4): 479-486.
49. Johnson et al., 2003. Metabolic fingerprinting of salt-stressed tomatoes. Phytochemistry, 62(6): 919-928. (Pubitemid 36262395)
50. Jones, 1999. Genetic and evolutionary algorithms, in: Encyclopedia of Computational Chemistry, Wiley.
51. Jong et al., 2004. Analysis of Proteomic Pattern Data for Cancer Detection. In Applications of Evolutionary Computing. EvoBIO: Evolutionary Computation and Bioinformatics. Springer, 2004. LNCS, 3005: 41-51
52. Jorissen and Gilson, 2005. Virtual Screening of Molecular Databases Using a Support Vector Machine. J. Chern. Inf. Model, 45(3): 549-561 (Pubitemid 40795161)
53. Kell, 2002. Defence against the flood. Bioinformatics World, pp16-18.
54. Kim et al., 2004. Prediction of phosphorylation sites using SVMs. Bioinformatics, 20: 3179-3184. (Pubitemid 39619207)
55. Kless and Eitrich, 2004. Cytochrome P450 Classification of Drugs with Support Vector Machines Implementing the Nearest Point Algorithm. LNAI, 3303:191-205 (Pubitemid 41050332)
56. Koza, 1992.Genetic Programming: On the Programming of Computers by Means of Natural Selection; MIT Press
57. Koza et al., 2001. Reverse engineering of metabolic pathways from observed data using genetic programming. Pac. Symp. Biocomp, 2001,434-435.
58. Langdon and Barrett, 2004. Genetic programming in data mining for drug discovery. In Ghosh and Jain, eds., Evolutionary Computing in Data Mining, pp211-235. Springer.
59. Langdon et al., 2001. Genetic programming for combining neural networks for drug discovery. In Roy, et al. eds., Soft Computing and Industry Recent Applications, 597-608. Springer. Published 2002.
60. Langdon et al., 2002. Combining decision trees and neural networks for drug discovery. In Foster, et al. eds., EuroGP, LNCS 2278, 60-70.
61. Langdon et al., 2003a. Comparison of AdaBoost and genetic programming for combining neural networks for drug discovery. In Raidl, et al. eds., Applications of Evolutionary Computing, LNCS 2611, pp87-98.
62. Li et al., 2005. Degree prediction of malignancy in brain glioma using support vector machines. Computers in Biology and Medicine, In Press.
63. Li et al., 2005b. A robust hybrid between genetic algorithm and support vector machine for extracting an optimal feature gene subset. Genomics, 85(1): 16-23. (Pubitemid 39655687)
64. Lin et al., 2005. Piecewise hypersphere modeling by particle swarm optimization in QSAR studies of bioactivities of chemical compounds. J. Chern. Inf. Model., 45(3):535-541. (Pubitemid 40795159)
65. Listgarten et al., 2004. Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms. Clin. Cancer Res., 10: 2725-2737 (Pubitemid 38509148)
66. Liu et al., 2004. QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines. Journal of Computer-Aided Molecular Design 18(6): 389-399 (Pubitemid 40069137)
67. Liu et al., 2005. Preclinical in vitro screening assays for drug-like properties. Drug Discovery Today: Technologies, 2(2):179-185
68. Lu et al., 2004. QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression. J. Pharm. Biomed. Anal., 35:679-687. (Pubitemid 38757658)
69. Malossini et al., 2004. Assessment of SVM reliability for microarrays data analysis. In: proc. 2nd European Workshop on data mining and text mining for bioinformatics, Pisa, Italy, Sept. 2004.
70. Merkwirth et al., 2004. Ensemble Methods for Classification in Cheminformatics. 1. Chern. Inf. Comput. Sci., 44(6): 1971-1978
71. Miwakeichi et al., 2001. A comparison of non-linear non-parametric models for epilepsy data. Computers in Biology and Medicine, 31(1): 41-57
72. Moore and Hahn, 2004. An improved grammatical evolution strategy for hierarchical petri net modeling of complex genetic systems. In Raidl, et al. eds., Applications of Evolutionary Computing, LNCS 3005, pp63-72.
73. Moore et al., 2002. Symbolic discriminant analysis of microarray data in automimmune disease. Genetic Epidemiology, 23:57-69. (Pubitemid 34743157)
74. Muchnik, 2004. Influences on Breast Cancer Survival via SVM Classification in the SEER Database. http://dimacs.rutgers.edu/Events/2004/ abstracts/muchnik.htmI
75. Ng, 2004. Drugs-From Discovery to Approval. Wiley, New Jersey. ISBN: 0-471-60150-0
76. Nicolotti et al., 2002. Multiob jective optimization in quantitative structure-activity relationships: Deriving accurate and interpretable QSARs. Journal of Medicinal Chemistry, 45(23):5069-5080. (Pubitemid 35278703)
77. Norinder, 2003. Support vector machine models in drug design: applications to drug transport processes and QSAR using simplex optimisations and variable selection. Neurocomputing, 55(1-2): 337-346 (Pubitemid 37336683)
78. Ooi and Tan, 2003. Genetic algorithms applied to multi-class prediction for the analysis of gene expression data. Bioinformatics, 19(1):37-44. (Pubitemid 36150179)
79. Prados et al., 2004. Mining mass spectra for diagnosis and biomarker discovery of cerebral accidents Proteomics, 4(8): 2320-2332
80. Ratti and Trist, 2001. Continuing evolution of the drug discovery process in the pharmaceutical industry. Pure Appl. Chern.. 73(1):67-75
81. Reif et al., 2004. Integrated analysis of genetic, genomic, and proteomic data. Expert Review of Proteomics, 1(1):67-75. (Pubitemid 43826430)
82. Roses, 2002. Genome-based pharmacogenetics and the pharmaceutical industry. Nat. Rev. Drug Discov. 1(7):541-9 (Pubitemid 37361506)
83. Runarsson and Sigurdsson, 2004. Asynchronous parallel evolutionary model selection for support vector machines. Neural Information Processing - Lett. & Reviews, 3(3):59-67
84. Saigo et al., 2004. Protein homology detection using string alignment kernels Bioinformatics, 20: 1682-1689.
85. Schneider and Fechner, 2004. Advances in the prediction of protein targeting signals Proteomics, 4(6): 1571-1580
86. Schneider & Fechner, 2005. Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discovery, 4(8):649-663 (Pubitemid 41149759)
87. Schrattenholz ,2004. Proteomics: how to control highly dynamic patterns of millions of molecules and interpret changes correctly? Drug Discovery Today: Technologies, 1(1): 1-8 (Pubitemid 40197546)
88. Sebag et aI., 2004. ROC-based Evolutionary Learning: Application to Medical Data Mining. Artificial Evolution '03, 384-396 Springer-verlag, LNCS
89. Seike, et al., 2004. Proteomic signature of human cancer cells. Proteomics, 4(9): 2776-2788 (Pubitemid 39202177)
90. Shawe-Taylor and Cristianini, 2000. An introduction to support vector machines. CUP.
91. Shen et al., 2004. Hybridized particle swarm algorithm for adaptive structure training of multilayer feed-forward neural network: QSAR studies of bioactivity of organic compounds. Joumal of Computational Chemistry, 25:1726-1735.
92. Shyu et al., 2004. Multiple sequence alignment with evolutionary computation. GP&EM, 5(2): 121-144. (Pubitemid 38497845)
93. Simek et al., 2004. Using SVD and SVM methods for selection, classification, clustering and modeling of DNA microarray data. Engineering Applications of Artificial Intelligence, 17: 417-427
94. Smits et al., 2005. Variable selection in industrial datasets using pareto genetic programming. In Yu, et al. eds., Genetic Programming Theory and Practice III. Kluwer.
95. Solmajer and Zupan, 2004. Optimisation algorithms and natural computing in drug discovery. Drug Discovery Today: Technologies, 1(3): 247-252 (Pubitemid 40197573)
96. Suwa et al., 2004. GPCR and G-protein Coupling Selectivity Prediction Based on SVM with Physico-Chemical Parameters. GIW 2004 Poster Abstract: P056. http://www.jsbi.org/journaIlGIW04/GIW04Poster.html
97. Takahashi et al., 2005. Identification of Dopamine Dl Receptor Agonists and Antagonists under Existing Noise Compounds by TFS-based ANN and SVM. J. Comput. Chern. Jpn., 4(2): 43-48
98. Takaoka et al., 2003. Development of a Method for Evaluating Drug-Likeness and Ease of Synthesis Using a Data Set in Which Compounds Are Assigned Scores Based on Chemists' Intuition. J. Chern. Inf. Comput. Sci., 43(4): 1269-1275.
99. Teramoto et al., 2005. Prediction of siRNA functionality using generalized string kernel and support vector machine. FEBS Lett. 579(13):2878-82 (Pubitemid 40725261)
100. Thukral et al., 2005. Prediction of Nephrotoxicant Action and Identification of Candidate Toxicity-Related Biomarkers. Toxicologic Pathology, 33(3): 343-355 (Pubitemid 40617138)
101. Tobita et al., 2005. A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors Bioorganic & Medicinal Chemistry Letters, 15:2886-2890
102. Vinayagam et al., 2004. Appplying support vector machines for gene ontology based gene function prediction. BMC Bioinformatics. 5:116-129
103. Tsai and Wang, 2005. Evolutionary optimization with data collocation for reverse engineering of biological networks. Bioinformatics, 21(7): 1180-1188. (Pubitemid 40467943)
104. Vapnik, V. N. The Nature of Statistical Learning Theory; Springer: New York, 1995.
105. Wachowiak et al., 2004. An approach to multimodal biomedical image registration utilizing particle swarm optimization. IEEE Trans on EC, 8(3):289-301.
106. Wang et al., 2004. Particle swarm optimization and neural network application for QSAR. In HiCOMB.
107. Wang et al., 2005. Gene selection from microarray data for cancer classification - a machine learning approach. Computational Biology and Chemistry, 29(1): 37-46 (Pubitemid 40146365)
108. Warmuth et al., 2003. Active Learning with Support Vector Machines in the Drug Discovery Process. 1. Chern. Inf. Comput. Sci., 43(2): 667-673
109. Watkins and German, 2002. Metabolomics and biochemical profiling in drug discovery and development. CurroOpin. Mol. Ther., 4(3): 224-8 (Pubitemid 35282867)
110. Xiao et al., 2003. Gene clustering using self-organizing maps and particle swarm optimization. In HiCOMB
111. Xu and Hagler 2002. Chemoinformatics and drug discovery. Molecules, 7: 566-600 (Pubitemid 38999114)
112. Xue et al., 2004a. Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach. J. Chern. Inf. Comput. Sci. 44(4): 1497-1505
113. Xue, et al., 2004b. QSAR Models for the Prediction of Binding Affinities to Human Serum Albumin Using the Heuristic Method and a Support Vector Machine. J. Chern. Inf. Comput. Sci.,44(5): 1693-1700
114. Yang and Chou, 2004. Bio-support vector machines for computational proteomics. Bioinformatics, 20: 735-741. (Pubitemid 38443829)
115. Yap and Chen, 2005. Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines. J. Chern. Inf. Model, To appear.
116. Yap et al., 2004. Prediction of Torsade-Causing Potential of Drugs by Support Vector Machine Approach. Toxicol. Sci., 79: 170-177 (Pubitemid 38660260)
117. Yoon et al., 2003. Analysis of Multiple Single Nucleotide Polymorphisms of Candidate Genes Related to Coronary Heart Disease Susceptibility by Using Support Vector Machines. Clinical Chemistry and Laboratory Medicine, 41(4): 529-534. (Pubitemid 36592120)
118. Zhao et al., 2004. Diagnosing anorexia based on partial least squares, back-propagation neural network, and support vector machines. J. Chern. Inf. Sci. 44, 2040-2046.